Want to see VTVT full AI Analyst Report?
vTv Therapeutics (VTVT) Income Statement
vTv Therapeutics Income Statement
Last quarter (Q2 2026), vTv Therapeutics's total revenue was $0.00. In Q2, vTv Therapeutics's net income was $-13.05M. See vTv Therapeutics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 1.02M | $ 0.00 | $ 2.02M | $ 4.00M | |
| $ 0.00 | $ 1.02M | $ 0.00 | $ 2.02M | $ 4.00M | |
| $ 32.81M | $ 25.20M | $ 25.50M | $ 24.56M | $ 25.67M | |
| Depreciation and Amortization | $ 16.00K | $ 89.00K | $ 90.00K | $ 92.00K | $ 89.00K |
| $ -31.06M | $ -22.52M | $ -25.86M | $ -24.77M | $ -17.52M | |
| $ -32.81M | $ -24.18M | $ -25.50M | $ -22.54M | $ -21.66M | |
| $ 1.73M | $ 1.57M | $ -464.00K | $ -2.33M | $ 4.05M | |
| $ -31.08M | $ -22.61M | $ -25.97M | $ -24.87M | $ -17.62M | |
| $ -26.97M | $ -18.46M | $ -20.25M | $ -19.16M | $ -12.99M | |
| Per Share Metrics | |||||
| Basic EPS | $ -3.20 | $ -3.20 | $ -9.71 | $ -9.98 | $ -8.29 |
| Diluted EPS | $ -3.20 | $ -3.20 | $ -9.71 | $ -9.98 | $ -8.29 |
| Weighted Average Shares Outstanding | 8.42M | 5.77M | 2.08M | 1.92M | 1.57M |
| Weighted Average Shares Outstanding (Diluted) | 8.42M | 5.77M | 2.08M | 1.92M | 1.57M |
Currency in USD
